Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Pulmonary Hypertension

  Free Subscription


Articles published in Chest

Retrieve available abstracts of 62 articles:
HTML format
Text format



Single Articles


    May 2019
  1. SINGH I, Oliveira RKF, Naeije R, Rahaghi FN, et al
    Pulmonary Vascular Distensibility and Early Pulmonary Vascular Remodeling in Pulmonary Hypertension.
    Chest. 2019 May 20. pii: S0012-3692(19)31063-3. doi: 10.1016/j.chest.2019.
    PubMed     Text format     Abstract available


    April 2019
  2. ALTSCHUL E, Remy-Jardin M, Machnicki S, Sulica R, et al
    Imaging of pulmonary hypertension: Pictorial essay.
    Chest. 2019 Apr 11. pii: S0012-3692(19)30826-8. doi: 10.1016/j.chest.2019.
    PubMed     Text format     Abstract available


    March 2019
  3. BUNEL V, Guyard A, Dauriat G, Danel C, et al
    Pulmonary Arterial Histological Lesions in COPD Patients with Severe Pulmonary Hypertension.
    Chest. 2019 Mar 11. pii: S0012-3692(19)30616-6. doi: 10.1016/j.chest.2019.
    PubMed     Text format     Abstract available


    February 2019
  4. BRAGANZA M, Shaw J, Solverson K, Vis D, et al
    A prospective evaluation of the diagnostic accuracy of the physical examination for pulmonary hypertension.
    Chest. 2019 Feb 28. pii: S0012-3692(19)30204-1. doi: 10.1016/j.chest.2019.
    PubMed     Text format     Abstract available


  5. DODSON MW, Allen-Brady K, Brown LM, Elliott CG, et al
    Chronic Thromboembolic Pulmonary Hypertension Cases Cluster in Families.
    Chest. 2019;155:384-390.
    PubMed     Text format     Abstract available


    August 2018
  6. HEMNES AR, Opotowsky AR, Assad TR, Xu M, et al
    Features Associated with Discordance between Pulmonary Arterial Wedge Pressure and Left Ventricular End Diastolic Pressure in Clinical Practice: Implications for Pulmonary Hypertension Classification.
    Chest. 2018 Aug 24. pii: S0012-3692(18)32250.
    PubMed     Text format     Abstract available


    July 2018
  7. TEJWANI V, Patel DC, Zein J, Guzman JA, et al
    Survival After an ICU Hospitalization for Pulmonary Hypertension.
    Chest. 2018;154:229-231.
    PubMed     Text format    


    May 2018
  8. KOLSTAD KD, Li S, Steen V, Chung L, et al
    Long-term Outcomes in Systemic Sclerosis Associated Pulmonary Arterial Hypertension from the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry (PHAROS).
    Chest. 2018 May 16. pii: S0012-3692(18)30736-0. doi: 10.1016/j.chest.2018.
    PubMed     Text format     Abstract available


  9. TANIGUCHI Y, Brenot P, Jais X, Garcia C, et al
    Poor Subpleural Perfusion Predicts Failure after Balloon Pulmonary Angioplasty for non-operable Chronic Thromboembolic Pulmonary Hypertension.
    Chest. 2018 May 3. pii: S0012-3692(18)30659-7. doi: 10.1016/j.chest.2018.
    PubMed     Text format     Abstract available


    April 2018
  10. MATHAI SC, Mathew S
    Breathing (and Coding?) a Bit Easier: Changes to International Classification of Disease Coding for Pulmonary Hypertension.
    Chest. 2018 Apr 20. pii: S0012-3692(18)30568-3. doi: 10.1016/j.chest.2018.
    PubMed     Text format     Abstract available


    January 2018
  11. NAEIJE R, Saggar R, Badesch D, Rajagopalan S, et al
    Exercise-Induced Pulmonary Hypertension Translating Pathophysiological Concepts into Clinical Practice.
    Chest. 2018 Jan 27. pii: S0012-3692(18)30161-2. doi: 10.1016/j.chest.2018.
    PubMed     Text format     Abstract available


    December 2017
  12. KHOURI C, Lepelley M, Roustit M, Montastruc F, et al
    Comparative safety of drugs targeting the nitric oxide pathway in pulmonary hypertension: a mixed approach combining a meta-analysis of clinical trials and a disproportionality analysis from the WHO pharmacovigilance database.
    Chest. 2017 Dec 21. pii: S0012-3692(17)33265-8. doi: 10.1016/j.chest.2017.
    PubMed     Text format     Abstract available


  13. HILL NS, Gillespie MN, McMurtry IF
    Fifty Years of Monocrotaline-Induced Pulmonary Hypertension: What Has It Meant to the Field?
    Chest. 2017;152:1106-1108.
    PubMed     Text format    


    October 2017
  14. CHADDHA U, Puscas I, Prosper A, Ganesh S, et al
    A 63-Year-Old Woman With Neurofibromatosis Type 1 and Pulmonary Hypertension With Worsening Hypoxemia.
    Chest. 2017;152:e89-e93.
    PubMed     Text format     Abstract available


    August 2017
  15. HACHULLA E, Jais X, Cinquetti G, Clerson P, et al
    Pulmonary arterial hypertension associated with systemic lupus: results from the French Pulmonary Hypertension Registry.
    Chest. 2017 Aug 26. pii: S0012-3692(17)31430-7. doi: 10.1016/j.chest.2017.
    PubMed     Text format     Abstract available


    July 2017
  16. RAMJUG S, Hussain N, Hurdman J, Billings C, et al
    Idiopathic and Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: A Comparison of Demographic, Hemodynamic, and MRI Characteristics and Outcomes.
    Chest. 2017;152:92-102.
    PubMed     Text format     Abstract available


    June 2017
  17. KAY JM
    Crotalaria (Monocrotaline) Pulmonary Hypertension: The Fiftieth Anniversary.
    Chest. 2017 Jun 19. pii: S0012-3692(17)31082-6. doi: 10.1016/j.chest.2017.
    PubMed     Text format    


  18. HARARI S, Elia D, Humbert M
    Pulmonary hypertension in parenchymal lung diseases: any future for new therapies?
    Chest. 2017 Jun 16. pii: S0012-3692(17)31077-2. doi: 10.1016/j.chest.2017.
    PubMed     Text format     Abstract available


  19. WAXMAN AB, McElderry HT, Gomberg-Maitland M, Burke MC, et al
    Totally Implantable Intravenous Treprostinil Therapy in Pulmonary Hypertension: Assessment of the Implantation Procedure.
    Chest. 2017 Jun 2. pii: S0012-3692(17)31021-8. doi: 10.1016/j.chest.2017.
    PubMed     Text format     Abstract available


    May 2017
  20. JOSE A, King CS, Shlobin OA, Kiernan JM, et al
    Ventricular diastolic pressure ratio as a marker of treatment response in pulmonary hypertension.
    Chest. 2017 May 17. pii: S0012-3692(17)30929-7. doi: 10.1016/j.chest.2017.
    PubMed     Text format     Abstract available


  21. AVIRAM G, Rozenbaum Z, Ziv-Baran T, Berliner S, et al
    Identification of Pulmonary Hypertension Caused by Left Heart Disease (World Health Organization Group 2) Based on Cardiac Chamber Volumes Derived from Chest CT.
    Chest. 2017 May 12. pii: S0012-3692(17)30917-0. doi: 10.1016/j.chest.2017.
    PubMed     Text format     Abstract available


  22. RAEISI-GIGLOU P, Wang XF, Dakkak W, Bair N, et al
    Effect of Weight on Parenteral Prostacyclin Analogues Dosing in Pulmonary Hypertension.
    Chest. 2017;151:1189-1192.
    PubMed     Text format    


    April 2017
  23. BEST DH, Sumner KL, Smith BP, Damjanovich-Colmenares K, et al
    EIF2AK4 Mutations in Patients Diagnosed With Pulmonary Arterial Hypertension.
    Chest. 2017;151:821-828.
    PubMed     Text format     Abstract available


    March 2017
  24. TAKEI M, Kawakami T, Kataoka M, Kuwahira I, et al
    Elucidating the Ventilation/Perfusion Mismatch and Reduction of Diffusing Capacity for Carbon Monoxide in Chronic Thromboembolic Pulmonary Hypertension.
    Chest. 2017;151:725-726.
    PubMed     Text format    


  25. ZHOU Q, Wang D, Liu Y, Yang X, et al
    Solnatide Demonstrates Profound Therapeutic Activity in a Rat Model of Pulmonary Edema Induced by Acute Hypobaric Hypoxia and Exercise.
    Chest. 2017;151:658-667.
    PubMed     Text format     Abstract available


    January 2017
  26. MEHTA S, Sastry BK, Souza R, Torbicki A, et al
    Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension: Results From the Randomized Controlled SERAPHIN Trial.
    Chest. 2017;151:106-118.
    PubMed     Text format     Abstract available


  27. JAIN S, Khera R, Girotra S, Badesch D, et al
    Comparative Effectiveness of Pharmacologic Interventions for Pulmonary Arterial Hypertension: A Systematic Review and Network Meta-Analysis.
    Chest. 2017;151:90-105.
    PubMed     Text format     Abstract available


    December 2016
  28. ZUCKER MJ
    Point: Should wireless pulmonary artery hemodynamic monitoring be used to monitor patients with pulmonary hypertension? YES.
    Chest. 2016 Dec 22. pii: S0012-3692(16)62632-6. doi: 10.1016/j.chest.2016.
    PubMed     Text format    


  29. HEMNES AR
    Counterpoint: Should wireless pulmonary artery hemodynamic monitoring be used to monitor patients with pulmonary hypertension? No.
    Chest. 2016 Dec 22. pii: S0012-3692(16)62629-6. doi: 10.1016/j.chest.2016.
    PubMed     Text format    


    November 2016
  30. SAHAY S, Melendres-Groves L, Pawar L, Cajigas HR, et al
    Pulmonary Hypertension Care Center Network Improving care and outcomes in PH.
    Chest. 2016 Nov 3. pii: S0012-3692(16)62331-0. doi: 10.1016/j.chest.2016.
    PubMed     Text format     Abstract available


    October 2016
  31. AKIZUKI M, Serizawa N, Ueno A, Adachi T, et al
    Effect of balloon pulmonary angioplasty on respiratory function in patients with chronic thromboembolic pulmonary hypertension.
    Chest. 2016 Oct 13. pii: S0012-3692(16)60761-4. doi: 10.1016/j.chest.2016.
    PubMed     Text format     Abstract available


    September 2016
  32. KATAOKA M, Momose Y, Aimi Y, Fukuda K, et al
    Familial Chronic Thromboembolic Pulmonary Hypertension in a Pair of Japanese Brothers.
    Chest. 2016;150:748-9.
    PubMed     Text format    


    August 2016
  33. D'ALTO M, Romeo E, Argiento P, Motoji Y, et al
    Clinical relevance of fluid challenge in patients evaluated for pulmonary hypertension.
    Chest. 2016 Aug 26. pii: S0012-3692(16)57833.
    PubMed     Text format     Abstract available


  34. SHLOBIN OA, Brown AW, Nathan SD
    Pulmonary Hypertension in Diffuse Parenchymal Lung Diseases.
    Chest. 2016 Aug 20. pii: S0012-3692(16)56163-7. doi: 10.1016/j.chest.2016.
    PubMed     Text format     Abstract available


    July 2016
  35. BOURGE RC, Waxman AB, Gomberg-Maitland M, Shapiro SM, et al
    Treprostinil Administered to Treat Pulmonary Arterial Hypertension Using a Fully Implantable Programmable Intravascular Delivery System: Results of the DelIVery for PAH Trial.
    Chest. 2016;150:27-34.
    PubMed     Text format     Abstract available


  36. MATURA LA, Shou H, Fritz JS, Smith KA, et al
    Physical Activity and Symptoms in Pulmonary Arterial Hypertension.
    Chest. 2016;150:46-56.
    PubMed     Text format     Abstract available


    June 2016
  37. GHOFRANI HA, Humbert M, Langleben D, Schermuly R, et al
    Riociguat: Mode of action and clinical development in pulmonary hypertension.
    Chest. 2016 Jun 2. pii: S0012-3692(16)49111-7. doi: 10.1016/j.chest.2016.
    PubMed     Text format     Abstract available


  38. HUERTAS A, Phan C, Bordenave J, Tu L, et al
    Regulatory T Cell Dysfunction in Idiopathic, Heritable and Connective Tissue-Associated Pulmonary Arterial Hypertension.
    Chest. 2016;149:1482-93.
    PubMed     Text format     Abstract available


    May 2016
  39. FRITZ JS, Smith KA
    The Pulmonary Hypertension Consult: Clinical and Coding Considerations.
    Chest. 2016 May 14. pii: S0012-3692(16)49006-9. doi: 10.1016/j.chest.2016.
    PubMed     Text format     Abstract available


  40. ROSE JA, Cleveland JM, Rao Y, Minai OA, et al
    Effect of Age on Phenotype and Outcomes in Pulmonary Arterial Hypertension Trials.
    Chest. 2016;149:1234-44.
    PubMed     Text format     Abstract available


  41. MAR PL, Nwazue V, Black BK, Biaggioni I, et al
    Valsalva Maneuver in Pulmonary Arterial Hypertension: Susceptibility to Syncope and Autonomic Dysfunction.
    Chest. 2016;149:1252-60.
    PubMed     Text format     Abstract available


  42. MEHARI A, Klings ES
    Chronic Pulmonary Complications of Sickle Cell Disease.
    Chest. 2016;149:1313-24.
    PubMed     Text format     Abstract available


  43. WELLS JM, Morrison JB, Bhatt SP, Nath H, et al
    Pulmonary Artery Enlargement Is Associated With Cardiac Injury During Severe Exacerbations of COPD.
    Chest. 2016;149:1197-204.
    PubMed     Text format     Abstract available


    April 2016
  44. DESMARAIS J, Elliott CG
    Familial Chronic Thromboembolic Pulmonary Hypertension.
    Chest. 2016;149:e99-e101.
    PubMed     Text format     Abstract available


  45. KWON Y, Gomberg-Maitland M, Pritzker M, Thenappan T, et al
    Telangiectasia and Pulmonary Arterial Hypertension Following Treatment With Trastuzumab Emtansine: A Case Report.
    Chest. 2016;149:e103-5.
    PubMed     Text format     Abstract available


  46. REXHAJ E, Rimoldi SF, Pratali L, Brenner R, et al
    Sleep-Disordered Breathing and Vascular Function in Patients With Chronic Mountain Sickness and Healthy High-Altitude Dwellers.
    Chest. 2016;149:991-8.
    PubMed     Text format     Abstract available


    March 2016
  47. ELLIOTT CG
    Use of Parenteral Prostanoids: Important Insights for CHEST Physicians.
    Chest. 2016;149:615-6.
    PubMed     Text format    


  48. RENARD S, Borentain P, Salaun E, Benhaourech S, et al
    Severe Pulmonary Arterial Hypertension in Patients Treated for Hepatitis C With Sofosbuvir.
    Chest. 2016;149:e69-73.
    PubMed     Text format     Abstract available


  49. HAY BR, Pugh ME, Robbins IM, Hemnes AR, et al
    Parenteral Prostanoid Use at a Tertiary Referral Center: A Retrospective Cohort Study.
    Chest. 2016;149:660-6.
    PubMed     Text format     Abstract available


    February 2016
  50. HASLER ED, Muller-Mottet S, Furian M, Saxer S, et al
    Pressure-flow during exercise catheterization predicts survival in pulmonary hypertension.
    Chest. 2016 Feb 15. pii: S0012-3692(16)01253-8. doi: 10.1016/j.chest.2016.
    PubMed     Text format     Abstract available


  51. AGARWAL R, Gomberg-Maitland M
    Physiologic Markers of Exercise as a Potential Screening Tool for the Detection of Pulmonary Hypertension: "alpha" Few Steps Forward.
    Chest. 2016;149:295-7.
    PubMed     Text format    


  52. LAU EM, Chemla D, Godinas L, Zhu K, et al
    Loss of Vascular Distensibility During Exercise Is an Early Hemodynamic Marker of Pulmonary Vascular Disease.
    Chest. 2016;149:353-61.
    PubMed     Text format     Abstract available


    January 2016
  53. HOPPER RK, Abman SH, Ivy DD
    Persistent Challenges in Pediatric Pulmonary Hypertension.
    Chest. 2016 Jan 22. pii: S0012-3692(16)00469-4. doi: 10.1016/j.chest.2016.
    PubMed     Text format     Abstract available


    October 2015
  54. GERGES C, Gerges M, Skoro-Sajer N, Zhou Y, et al
    Hemodynamic thresholds for pre-capillary pulmonary hypertension.
    Chest. 2015 Oct 22. doi: 10.1378/chest.15-0928.
    PubMed     Text format     Abstract available


  55. RICHTER SE, Roberts KE, Preston IR, Hill NS, et al
    A simple derived prediction score for the identification of an elevated pulmonary artery wedge pressure using pre-catheterization clinical data in patients referred to a pulmonary hypertension center.
    Chest. 2015 Oct 22. doi: 10.1378/chest.15-0819.
    PubMed     Text format     Abstract available


  56. BONHAM CA, Oldham JM, Gomberg-Maitland M, Vij R, et al
    Prostacyclin and Oral Vasodilator Therapy in Sarcoidosis-Associated Pulmonary Hypertension: A Retrospective Case Series.
    Chest. 2015;148:1055-62.
    PubMed     Text format     Abstract available


  57. HAUTEFORT A, Girerd B, Montani D, Cohen-Kaminsky S, et al
    Response.
    Chest. 2015;148:e132-3.
    PubMed     Text format    


  58. HARBAUM L, Oqueka T, Glatzel A, Hennigs JK, et al
    Does circulating IL-17 identify a subset of patients with idiopathic pulmonary arterial hypertension?
    Chest. 2015;148:e131-2.
    PubMed     Text format    


  59. GAZZANA MB, Knorst MM
    Therapy for pulmonary arterial hypertension: approved dosages should be prescribed in clinical practice.
    Chest. 2015;148:e126.
    PubMed     Text format    


  60. FARBER HW, Miller DP, Poms AD, Badesch DB, et al
    Five-Year outcomes of patients enrolled in the REVEAL Registry.
    Chest. 2015;148:1043-54.
    PubMed     Text format     Abstract available


    September 2015
  61. PLOEGSTRA MJ, Arjaans S, Zijlstra WM, Douwes JM, et al
    Clinical Worsening as Composite Study End Point in Pediatric Pulmonary Arterial Hypertension.
    Chest. 2015;148:655-66.
    PubMed     Text format     Abstract available


    January 2015
  62. GUAZZI M, Naeije R, Arena R, Corra U, et al
    Echocardiography of Right Ventriculo-Arterial Coupling Combined to Cardiopulmonary Exercise Testing to Predict Outcome in Heart Failure.
    Chest. 2015 Jan 29. doi: 10.1378/chest.14-2065.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: